The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2014
Filed:
Nov. 08, 2012
Applicant:
Pharmascience Inc., Montreal, CA;
Inventors:
Alain Boudreault, Dorval, CA;
James Jaquith, Pincourt, CA;
Patrick Bureau, Kirkland, CA;
John W. Gillard, Baie d'Urfé, CA;
Alain Laurent, Montreal, CA;
Assignee:
Pharmascience Inc., Montreal, Quebec, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2006.01); A61K 38/00 (2006.01); A61K 31/40 (2006.01); A61K 31/4025 (2006.01); C07K 7/06 (2006.01); A61K 38/17 (2006.01); C07K 5/083 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1761 (2013.01); A61K 38/00 (2013.01); A61K 38/08 (2013.01); A61K 31/40 (2013.01); A61K 31/4025 (2013.01); C07K 7/06 (2013.01); C07K 5/0806 (2013.01); C07K 5/0808 (2013.01); C07K 5/081 (2013.01);
Abstract
Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II or a salt thereof, in which R, R, R, R, R, R, A, A, BG, Q and Qare substituents described herein. Also disclosed is the use of compounds of Formula I and II to treat proliferative disorders such as cancer.